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Abstract. The activity of the mitosis-promoting kinase 
CDC2-cyclin B is normally suppressed in S phase and 
G2 by inhibitory phosphorylation at Thrl4 and Tyrl5. 
This work explores the possibility that these phosphor- 
ylations are responsible for the G2 arrest that occurs in 
human cells after DNA damage. HeLa cell lines were 
established in which CDC2AF, a mutant that cannot be 
phosphorylated at Thrl4 and Tyrl5, was expressed 
from a tetracycline-repressible promoter. Expression of 
CDC2AF did not induce mitotic events in cells arrested 
at the beginning of S phase with DNA synthesis inhibi- 
tors, but induced low levels of premature chromatin 
condensation in cells progressing through S phase and 
G2. Expression of CDC2AF greatly reduced the G2 de- 
lay that resulted when ceils were X-irradiated in S 
phase. However, a significant G2 delay was still ob- 
served and was accompanied by high CDC2-associated 
kinase activity. Expression of wild-type CDC2, or the 
related kinase CDK2AF, had no effect on the radia- 
tion-induced delay. Thus, inhibitory phosphorylation of 
CDC2, as well as additional undefined mechanisms, de- 
lay mitosis after DNA damage. 
I 
N eukaryotic cells, the initiation of mitosis requires the 
activity of the cyclin-dependent protein kinase, CDC2 
(Nurse, 1990; Dunphy, 1994; King et al., 1994). CDC2 
activation is a complex process that begins with the bind- 
ing of CDC2  to  a  positive regulatory subunit, cyclin B, 
whose levels gradually increase during S phase and G2 and 
reach a maximum at mitosis. Before mitosis, it is thought 
that the CDC2-cyclin B complex is held in an inactive state 
by phosphorylation at Thrl4 and Tyrl5, which is catalyzed 
by Wee1 and related protein kinases (Nurse, 1990; Dun- 
phy, 1994; King et al.,  1994; Mueller et al., 1995). At the 
end of G2, abrupt dephosphorylation of these sites by the 
phosphatase CDC25 triggers CDC2 activation. 
Dephosphorylation  of  inhibitory  sites  in  CDC2  is 
thought to be a key determinant of mitotic timing in the 
fission yeast, Schizosaccharomyces pombe, where genetic 
defects that reduce Tyrl5 phosphorylation lead to prema- 
ture mitosis (Gould and Nurse, 1989). The timing of mito- 
sis  during postblastoderm  development in Drosophila  is 
also  controlled by dephosphorylation of inhibitory sites 
(Edgar and O'Farrell, 1989, 1990). The importance of in- 
hibitory phosphorylation is less clear in mammalian cells, 
where premature mitotic events occur to limited extents in 
transiently transfected cells  overexpressing  CDC2AF,  a 
mutant  form  of  CDC2  in  which  Thrl4  and  Tyrl5  are 
changed to alanine and phenylalanine, respectively (Krek 
and Nigg, 1991; Heald et al.,  1993). In the budding yeast, 
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Saccharomyces cerevisiae, mutation of the equivalent resi- 
dues  has  no  clear  impact  on  normal  cell  cycle  timing 
(Amon et al., 1992; Sorger and Murray, 1992; Booher et al., 
1993; Stueland et al., 1993), although these mutations dis- 
rupt the coordination of mitosis with bud emergence (Lew 
and Reed, 1995). 
Cell cycle checkpoints normally ensure that mitosis does 
not  occur  until  DNA  replication  is  complete  (Murray, 
1994a,b).  In  S,  pombe,  preventing  phosphorylation  of 
Tyrl5 leads to mitosis even in the presence of chemical in- 
hibitors  of  DNA  synthesis,  suggesting  that  incomplete 
DNA replication normally restrains mitosis by stabilizing 
Tyrl5  phosphorylation (Enoch and  Nurse,  1990).  How- 
ever, in S. cerevisiae (Amon et al., 1992; Sorger and Mur- 
ray, 1992; Booher et al., 1993; Stueland et al., 1993) and in 
the early embryos of Xenopus laevis (Kumagai and Dun- 
phy, 1995), there is evidence that dephosphorylation of the 
inhibitory sites is not sufficient to induce premature mito- 
sis when DNA synthesis is blocked. 
DNA  damage also blocks the initiation of mitosis. In 
both fission and budding yeasts, the cell cycle arrest in- 
duced by DNA  damage is  not affected when inhibitory 
phosphorylation is prevented, suggesting that some other 
mechanism delays mitosis under these conditions (Amon 
et al.,  1992; Sorger and Murray, 1992; Barbet and Carr, 
1993; Booher et al., 1993; Sheldrick and Carr, 1993; Stue- 
land et al.,  1993). In mammalian cells arrested in G2 by 
DNA damage, some fraction of the CDC2 in the cell is 
phosphorylated at  the  inhibitory sites  (Hofmann et  al., 
1994; Kharbanda et al., 1994; Herzinger et al., 1995; Paules 
et al.,  1995), but it is not known if this phosphorylation is 
required for G2 arrest. 
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CDC2 phosphorylation in the mitotic delay that occurs af- 
ter DNA damage in mammalian cells. We have developed 
human  cell  lines  in  which  we  can  inducibly  express  the 
CDC2AF  mutant.  Expression of this protein results in a 
substantial decrease in the mitotic delay that occurs after 
DNA damage, indicating that inhibitory phosphorylation 
does play a  role in  CDC2 regulation  under  these  condi- 
tions.  However,  expression  of CDC2AF  does  not  com- 
pletely abolish G2 arrest, indicating that additional inhibi- 
tory mechanisms also restrain mitosis after DNA damage. 
Materials and Methods 
Cell Lines 
Hemagglutinin  (HA) I epitope-tagged CDC2,  CDC2AF,  and  CDK2AF 
were constructed as described (Desai et al., 1992; Gu et al., 1992) and sub- 
cloned into pUHDIO-3, in which they are driven by a tet operator fused to 
a  minimal  CMV promoter (Gossen and  Bujard,  1992). Plasmids were 
cotransfected with a hygromycin resistance plasmid into HtTA-1 cells, a 
HeLa cell derivative containing the pUHD15-1  neo plasmid expressing 
the tTA transactivator under the control of a CMV promoter (Gossen and 
Bujard, 1992).  Clones resistant to both neomycin and hygromycin were 
screened for inducible expression of HA-tagged CDC2 and CDK2. 
Cell Cycle Synchronization  and X-Irradiation 
Hela cells were synchronized with a double thymidine block protocol. Ex- 
ponentially proliferating cells maintained in DME/10% FCS/10 p-g/ml tet- 
racycline were arrested in S phase by treatment with thymidine (2 mM) 
for 17 h, and were released from the arrest by three washes in PBS (137 
mM NaC1, 2.7  mM  KC1, 4.3  mM Na2HPO4,  1.4 mM KH2PO4,  0.9 mM 
CaC12, 0.5 mM MgCl2, pH 7.3). Cells were grown in fresh medium for 9 h 
and then subjected to a second thymidine treatment. After 14 h, cells were 
washed three times with PBS to allow progress into S phase. In the half of 
the population where foreign protein expression was desired, tetracycline 
was removed throughout the entire synchronization, from the beginning 
of the first thymidine treatment. For ionizing radiation experiments, cells 
released from the Gf/S block for 1 h were X-irradiated at room tempera- 
ture with a 150-kV  Philips X-ray machine without a filter at a rate of 2.5 
Gray/min for a total dose of 6 Gray. 
For flow cytometric analysis of DNA synthesis and DNA content, cells 
were cultured in medium containing 10 I~M bromodeoxyuridine (BrdU) 
for 60 min before harvesting. Cells were trypsinized, fixed in 70% ethanol, 
and stained with FITC-conjugated a-BrdU antibodies and propidium io- 
dide (Larsen, 1994). Stained ceils were analyzed by a FACScan (Becton 
Dickinson, Mountain View, CA), and quantitation of S phase cells (la- 
beled by the FITC-conjugated a-BrdU) and G1 and G2/M cells (assessed 
by DNA content) was accomplished by a multiparameter assay with Lysis 
II software. 
Chromosome Spreading 
Chromosome spreading was performed as described (Heald et al., 1993). 
Briefly, rounded cells were gently collected by rinsing the dishes once with 
warm cell culture medium. The cells were pelleted and swollen by incuba- 
tion in 10 ml of hypotonic buffer (75 mM KC1) for 8 min. Swollen cells 
were centrifuged and fixed in methanol/acetic acid (3:1, vol/vol) for 8 rain. 
Drops of fixed cells were dropped from a distance of 1 m onto the surface 
of glass slides. Slides were dried and stained with HOECHST 33258. 
Biochemical  Procedures 
To prepare cell lysates, cells were detached from 10-cm dishes with a rub- 
ber policeman, harvested by centrifugation, and resuspended in 200 Ixl ly- 
sis buffer (10 mM Hepes pH 7.4, 10 mM NaC1, 1 mM EDTA, 0.1% Triton 
X-100, 50 mM NaF, 80 mM 13-glycerophosphate,  0.I mM Na3VO  4, 1 mM 
phenylmethylsulfonyl fluoride, 1 p-g/ml leupeptin, 20 U/ml aprotinin). Ly- 
1. Abbreviation used in this"  paper: HA, hemagglutinin. 
sates were clarified by centrifugation (10,000 g, 10 min, 4°C). To measure 
histone H1 kinase activity, cell lysate (50 p-g) was incubated for 1 h at 4°C 
with monoclonal anti-HA antibody 12CA5 (3 p-g), crude rabbit anti-cyclin 
B serum (0.5  p.l) (Pines and Hunter, 1989), or affinity-purified antibody 
against the COOH terminus of human CDC2 (0.5 p.g) (Rosenblatt et al., 
1992) bound to protein A-Sepharose (Sigma Chem. Co., St. Louis, MO). 
Immunoprecipitates were washed three times with HBS (10 mM Hepes, 
150 mM NaC1, pH 7.4)  +  0.1% Triton X-100,  twice with HBS +  1 mM 
dithiothreitol (DTT),  and incubated in HBS (30  txl) containing 10 mM 
MgCI2,  50  p-M ATP,  1  ~Ci  [~-32P]ATP  (3,000  mCi/mmol;  Amersham 
Corp., Arlington Heights, IL), 1 mM DTT and 5 Ixg of histone H1 (Boeh- 
ringer Mannheim Corp., Indianapolis, IN). After 5 min at 24°C, reaction 
products were analyzed by SDS-PAGE and autoradiography.  Immuno- 
blotting  was  performed using  the  ProtoBlot Western  blot  AP  System 
(Promega, Madison, WI). 
Results 
Inducible Expression of CDC2AF 
To study the role of inhibitory  CDC2 phosphorylation  in 
mitotic timing and the G2 arrest caused by DNA damage, 
Figure 1.  Inducible  expression of HA-tagged CDC2  and  CDK2 
in  HeLa  cells.  (A)  Cell  lines  expressing  HA-tagged  wild-type 
CDC2,  CDC2AF,  or  CDK2AF  were  cultured  in  the  presence 
(Tet  +) or absence (Tet  -)  of tetracycline (2 jxg/ml). Cell lysates 
(50 p~g) were analyzed by immunoblotting with the anti-HA anti- 
body 12CA5.  (B,  C, and D)  Lysates of cells cultured in  the ab- 
sence of tetracycline were immunoblotted with 12CA5  (B), anti- 
CDC2  (C),  or anti-PSTAIRE  (D)  antibody.  Approximate  sizes 
of the bands are indicated on the right. The anti-CDC2 antibody 
(Rosenblatt et  al.,  1992)  recognizes the COOH  terminus of en- 
dogenous CDC2  but  does not recognize the HA-tagged CDC2. 
Control lanes contain recombinant CDC2  (50  ng, B-D, lane 1), 
expressed  and  purified  from  Sf9  cells  as  described  previously 
(Desai et al., 1992). 
The Journal of Cell Biology, Volume  134, 1996  964 e-- 
0 
=  30 
¢- 
"o 
t- 
O 
<  20 
Z  ag 
~  ~  10 
e'J 
¢- 
=  0  Z 
CDC2AF 
8 
CDK2AF 
-Tet 
16  24  0  8  16  24 
Hours Post Release 
30 
20 
10 
Figure  2.  Conditional  ex- 
pression  of  CDC2AF  and 
CDK2AF  induces  prema- 
ture chromatin condensation 
in some cells. Cells were syn- 
chronized at the G1/S bound- 
ary  by  a  double  thymidine 
treatment in the presence or 
absence of tetracycline (2 Ixg/ 
ml).  At  various  times  after 
release from the G1/S block, 
cells were detached from tissue 
culture  dishes by trypsiniza- 
tion,  fixed  in  70%  ethanol, 
stained with HOECHST 33258, 
and examined by fluorescence 
microscopy. Photographs rep- 
resent CDC2AF-1 (A, B, and 
C) or CDK2AF (D, E, and F) 
cells 12 h  after release from 
the G1/S block, either in the 
presence  (A  and  D)  or  ab- 
sence (B, C, E, and F) of tet- 
racycline. (G) Frequencies of 
nuclear  DNA  abnormalities 
in  CDC2AF-1  or  CDK2AF 
clones after release from G1/S 
block. Cells with aberrant nu- 
clear DNA condensation were 
scored as a percentage of the 
total  cell nuclei  counted.  At 
least 300  cells were  counted 
from each sample. 
we established stable human  HeLa cell lines in which we 
could conditionally express wild-type human CDC2 or the 
CDC2AF  mutant  under  the  control  of  a  tetracycline- 
repressible promoter  (Gossen and Bujard,  1992).  All ex- 
periments  were  performed  with  two  different  CDC2AF 
clones, and identical results were obtained. We also stud- 
ied cell lines expressing an equivalent AF mutant form of 
CDK2,  a  CDK thought  to play a  role in the initiation or 
maintenance of DNA replication. All proteins contained a 
COOH-terminal  epitope  tag from  influenza  hemaggluti- 
nin (HA), which is recognized by the  12CA5 monoclonal 
antibody  (Desai  et  al.,  1992).  Expression  of the  various 
CDKs in these cell lines is very low when cells are cultured 
in the presence of tetracycline; removal of tetracycline in- 
creases expression dramatically (Fig. 1 A). Expression  is 
maximal within  12 h  of tetracycline removal (not shown). 
The HA-tagged wild-type CDC2 (Fig. 1 A, lane 2), as well 
as  endogenous  CDC2  (Fig.  1  C),  migrated on polyacryl- 
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duces abnormal chromatin spreading. 16 h following release from 
a G1/S block, rounded cells in the culture were collected by gen- 
tly  rinsing  the  cell  culture  dishes  with  warm  medium.  This 
method yields <1% of CDC2AF-1 cells grown in the presence of 
tetracycline,  and  ~9%  and  6%  of CDC2AF-1  and  CDK2AF 
cells,  respectively,  grown in the  absence  of tetracycline.  Cells 
were prepared for chromosome spreading as described in Materi- 
als  and  Methods.  (A)  A  normal  chromosome spread  from  a 
CDC2AF-1  cell  grown in  the  presence  of tetracycline.  (B)  A 
chromosome  spread  showing  the  extensive  fragmentation  in 
CDC2AF-1 cells in the absence of tetracycline. (C) Partial chro- 
matin condensation seen in CDK2AF cells in the absence of tet- 
racycline. (D) Frequencies of normal and abnormal chromosome 
spreads as a fraction of total nuclear spreads. Abnormal spreads 
were scored either as chromosome fragmentation (fragmented, 
as in B) or as partial chromatin condensation (partial, as in C). 
amide gels as closely spaced triplets; as demonstrated pre- 
viously (Norbury et al., 1991; Solomon et al., 1992), upper 
bands represent Thrl4- and Tyrl5-phosphorylated protein 
and are not seen in the HA-tagged CDC2AF mutant (Fig. 
1  A,  lanes  4  and  6).  CDK2AF migrates  as  a  doublet  in 
which the lower band  represents  protein  phosphorylated 
at the activating residue Thrl60 (Gu et al., 1992). 
We compared the  levels  of HA-tagged CDC2  and  en- 
dogenous CDC2 by immunoblotting cell lysates with anti- 
bodies against the conserved PSTAIRE epitope of CDKs 
(Fig. 1 D). CDC2 is the major immunoreactive protein in 
HeLa cells (the other major PSTAIRE antigen, CDK2, is 
expressed at about fourfold lower levels). Based on these 
immunoblots, we estimate  that the amount of HA-tagged 
CDC2 in these lines is approximately half the amount of 
endogenous CDC2. 
CDC2AF Expression Has Minor Effects on 
Mitotic Timing 
We found that conditional expression  of either CDC2AF 
or CDK2AF in an asynchronous population  reduced cell 
survival over a  period  of several  days.  Upon  removal  of 
tetracycline  from  the  culture  medium,  a  fraction  of the 
cells rounded  up and detached,  and cell  debris gradually 
accumulated in the culture medium (data not shown). To 
understand  the  cell cycle timing of these  effects, we per- 
formed  more  detailed  analyses  of cells  synchronized  at 
specific cell cycle stages. Cells were arrested  at the begin- 
ning of S phase by a  double thymidine block in the pres- 
ence or absence of tetracycline. Flow cytometry revealed 
that expression of CDC2AF or CDK2AF did not increase 
the DNA content of arrested cells (see Figs. 4 and 5 below, 
time  zero).  Microscopic analysis of cells  stained  with  the 
DNA  specific dye HOECHST  33258  confirmed  that  ex- 
pression of the mutant proteins in arrested cells did not re- 
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Figure 4.  Cell cycle progression in CDC2AF-1 cells. Cells were synchronized  by double thymidine treatment in the presence (+ Tet, a and 
c) or absence (- Tet, b and d) of tetracycline as in Fig. 2. 1 h after release from G1/S arrest, cells were X-irradiated (6 Gray, Plus I.R.) or 
received mock irradiation (No I.R.). At the indicated times after G1/S release, cells were incubated with BrdU, harvested, fixed, and in- 
cubated with FITC-conjugated anti-BrdU antibodies and propidium iodide as described in Materials and Methods. Stained cells were 
analyzed by flow cytometry to quantitate S phase cells (labeled by anti-BrdU) and G1 and G2/M cells (assessed by DNA content). DNA 
content profiles are shown in the figure, and quantitation of G1, S, and G2 cells is shown on the right. 
suit in ceil rounding or premature chromatin condensation 
(see Fig. 2 G below, time zero). 
When cells were released from the G1/S arrest in the ab- 
sence of tetracycline, abnormally condensed nuclear DNA 
was observed in  a  fraction of the  population, suggesting 
that premature chromatin condensation was occurring as 
the cells progressed through S phase and G2 (Fig.  2). The 
effects of CDC2AF and  CDK2AF were consistently dif- 
ferent: CDC2AF induced a slightly higher number of nu- 
clei with hypercondensed chromatin (Fig. 2 G), despite be- 
ing expressed at lower levels than CDK2AF (Fig. 1 A). In 
both cell lines,  however, the majority of cells displayed a 
nuclear DNA-staining pattern indistinguishable from that 
of the same cells grown in the presence of tetracycline. 
To further characterize the nature  of the chromosome 
abnormalities seen in these cell lines,  we performed chro- 
mosome spreading experiments.  Rounded cells were col- 
lected  16 h  after release from the G1/S block. A  normal 
chromosome spread with intact chromosomes is shown in 
Fig. 3 A. Spreads prepared from cells expressing CDC2AF 
displayed extensive chromosome fragmentation (Fig. 3 B), 
which is thought to result from premature mitotic events 
occurring during S phase (Heald et al.,  1993).  A  qualita- 
tively different pattern of partial chromatin condensation 
was observed in most of the  abnormal spreads prepared 
from CDK2AF-expressing cells (Fig. 3, C and D). 
Although  expression  of  CDC2AF  and  CDK2AF  in- 
duced hypercondensed nuclei in some cells, flow cytomet- 
ric analysis of DNA content and DNA synthesis in the to- 
tal  cell  population  revealed  that  expression  of  these 
proteins did not have significant effects on the timing of 
progression through S phase or mitosis  (Fig.  4, a  and b; 
and Fig. 5, a and b). 
CDC2AF Expression Partially Reduces the G2 Delay 
Caused by DNA Damage 
To test  the  role  of inhibitory CDC2  phosphorylation in 
Jin et al. CDC2  Phosphorylation  and Radiation  Arrest  967 DNA  damage-induced  mitotic  checkpoint  control,  we 
X-irradiated cells (6 Gray) during early S phase, 1 h after 
release from the G1/S arrest. Control cells received mock 
irradiation.  DNA synthesis and DNA content were then 
measured  by flow cytometry (Fig.  4).  Unirradiated  cells 
progressed from S to G2 between 4 and 8 h  after release 
from the  G1/S  block,  and  completed  mitosis  between  8 
and 12 h after release (Fig. 4, a and b). Irradiation resulted 
in slower progress through S phase, and induced an ,--~12 h 
mitotic  delay  (Fig.  4  c).  Only  18.2%  of irradiated  cells 
emerged in G1 24 h after release (Fig. 4 c), while 42.6% of 
unirradiated cells appeared in G1 as early as 12 h after re- 
lease (Fig. 4 a). 
Expression of CDC2AF resulted in partial abrogation of 
the radiation-induced G2 delay. In the absence of tetracy- 
cline, irradiated cells began to appear in G1 12 h after re- 
lease (Fig. 4 d), and we estimate that the mitotic delay due 
to irradiation was reduced from about 12 h in the absence 
of CDC2AF to ,--~4-6 h in its presence. Similar results were 
obtained  in  three  independent  experiments  with  two 
CDC2AF clones.  Only CDC2AF was able to induce this 
partial bypass of the radiation-induced G2 delay: we failed to 
detect any change in the delay in cells expressing CDK2AF 
(Fig. 5, c and d) or wild-type CDC2 (data not shown). 
Kinase Activity Associated with CDC2 and Cyclin B 
during G2 Arrest 
Analyses of CDC2  and cyclin B  levels and activity were 
performed to clarify the biochemical changes accompany- 
ing cell cycle progression in the above experiments (Fig. 6). 
In unirradiated cells grown in the presence of tetracycline 
(Fig. 6, lanes 1-5), CDC2- and cyclin B-associated kinase 
activities peaked 8  h  after G1/S  release  and  declined  as 
cells  progressed  into  G1  (see  Fig.  4  a).  Expression  of 
CDC2AF  resulted  in  abundant  CDC2AF-associated  ki- 
nase activity (Fig. 6 D, lanes 6-10), which peaked 8 h after 
G1/S  release, and then remained partially elevated after 
mitosis, perhaps due to an association with cyclin A  or B 
in the subsequent cell cycle. The presence of CDC2AF did 
not affect the timing of CDC2- and cyclin B-associated ac- 
tivities,  which  still  peaked  ,--,8 h  after G1/S  release  and 
then declined (Fig. 6, E  and F; lanes 6--10). These results 
are consistent with our flow cytometric evidence that the 
timing of mitosis in most cells is not affected by CDC2AF 
expression. 
To confirm that CDC2AF activity represents a  signifi- 
cant fraction of total CDC2-associated kinase activity, we 
immunodepleted CDC2AF-HA from lysates of cells har- 
vested 8 h  after G1/S release. Incubation with a large ex- 
cess of anti-HA antibody, followed by adsorption to pro- 
tein  A-Sepharose  and  centrifugation,  resulted  in  the 
removal of over 90% of the CDC2AF-HA from the lysate 
(data not shown).  Cyclin B-associated  kinase  activity in 
the immunodepleted lysate was ~40% lower than activity 
in a lysate incubated with beads alone, demonstrating that 
CDC2AF is responsible for about half of the cyclin B-asso- 
ciated activity in mitotic cells. 
Biochemical analyses of irradiated cells provided addi- 
tional  clues  about  the  importance  of  inhibitory  CDC2 
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Figure  5.  Cell  cycle  progression  in 
CDK2AF cells. Cells were subjected to 
the same treatments as those described 
for CDC2AF-1 in Fig. 4. DNA content 
profiles are shown for cells at the indi- 
cated times  after G1/S release,  in the 
presence (+  Tet, a and c) or absence 
(-  Tet, b and d) of tetracycline.  Cells 
received  X-irradiation  (Plus  I.R.)  or 
mock treatment (No I.R.). 
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tion on levels and activity of 
CDC2  and  cyclin  B1. 
CDC2AF-1  cells  were  syn- 
chronized  and  irradiated  in 
the  presence  or  absence  of 
tetracycline  as  described  in 
Fig. 4. At the indicated  times 
after  irradiation,  cells  were 
lysed and subjected  to analy- 
sis  by  immunoblotting  with 
anti-HA  (A),  anti-cyclin  B 
(B),  and  anti-CDC2  (C).  In 
addition,  histone  H1  kinase 
activity was measured in im- 
munoprecipitates  with  anti- 
HA (D), anti-cyclin B (E), or 
anti-CDC2  (F).  Autoradio- 
graphic  exposure times were 
3 h (D and F) or 1 h (E). 
phosphorylation in  DNA-damage-induced  arrest.  Radia- 
tion-induced  G2 arrest was accompanied by reduced  gel 
mobility of a small fraction of the endogenous CDC2 (Fig. 
6 C, lanes 11-15), reflecting phosphorylation at Thr14 and 
Tyrl5 as reported previously (Hofmann et al., 1994; Khar- 
banda et al., 1994; Paules et al., 1995).  Irradiation caused a 
transient delay in the accumulation of cyclin B1 and cyclin 
B1-CDC2-associated kinase activity (Fig. 6, B, E, and F, 
compare lanes 2 and 12), as previously reported (Muschel 
et al.,  1991,  1993; Maity et al., 1995).  After this initial de- 
lay, however, cyclin B1 levels and cyclin B1-CDC2-associ- 
ated  kinase  activity rose  to  and  remained  at  high  levels 
during the several hours that these cells were delayed in 
G2 (Fig. 6, B, E, and F; lanes 12-14; see Fig. 4 c). Expres- 
sion of CDC2AF led to the appearance of large amounts 
of CDC2AF-associated  kinase  activity at  all  time points 
(Fig. 6, A  and D; lanes 16-20). Once again, the reduced G2 
delay that occurred in  the  presence of CDC2AF was ac- 
companied  by  significant  amounts  of  cyclin  B1-  and 
CDC2-associated kinase activity (Fig. 6, E  and F, lanes 17 
and 18; see Fig. 4 c). Thus, both in the absence and pres- 
ence of the CDC2AF mutant, DNA-damage-induced G2 
arrest was accompanied by high levels of CDC2-associated 
kinase activity. 
Discussion 
Our  results  suggest  that  inhibitory  phosphorylation  of 
CDC2 plays a limited role in the suppression of mitosis in 
human  cells progressing  through  S  phase.  Expression  of 
the CDC2AF mutant (or CDK2AF) at approximately nor- 
mal  concentrations  did  not  induce  premature  mitotic 
events in cells arrested at G1/S by inhibitors of DNA syn- 
thesis, and induced only a low frequency of mitotic events 
in  cells progressing through  S  phase.  Thus, we  conclude 
that phosphorylation of Thrl4 and Tyrl5 is not solely re- 
sponsible for the repression of mitosis when DNA replica- 
tion is incomplete. 
These results are consistent with the results of Heald et al. 
(1993), who found that transient overexpression of CDC2AF 
resulted in abnormal chromatin condensation in only 12% 
of baby hamster kidney cells. We did not observe the high 
frequency of mitotic events seen in earlier studies of tran- 
siently  transfected  HeLa  cells  overexpressing  CDC2AF 
(Krek and Nigg, 1991).  These discrepancies may be due to 
differences in the level of CDC2AF expression. 
Why  are  premature  mitotic  events  infrequent  in  cells 
containing  abundant  quantities  of active CDC2AF?  One 
potential explanation comes from evidence that the initia- 
tion of mitosis is accompanied not just by CDC2 dephos- 
phorylation but by relocalization of cyclin from the cyto- 
plasm to the nucleus (Pines and Hunter, 1991; Ookata et al., 
1992; Pines and Hunter, 1994).  During S phase and G2, cy- 
clin B (with CDC2 attached) accumulates in the cytoplasm. 
Just before mitosis, these Cyclin B-CDC2 complexes enter 
the nucleus and initiate their mitotic functions. The impor- 
tance  of  this  change  of  subcellular  localization  is  sup- 
ported by the studies of Heald et al. (1993), who were able 
to  engineer  cells  containing  abundant  quantities  of de- 
phosphorylated,  active  CDC2  whose  activity  was  re- 
stricted to the cytoplasm. These active complexes did not 
induce premature mitotic events. Thus, active CDC2AF- 
cyclin B complexes may be ineffective in our experiments 
because they are restricted to the cytoplasm. Indeed, im- 
munofluorescence  studies  indicate  that  cells  expressing 
CDC2AF exhibit the normal pattern of cyclin B  localiza- 
tion (Jin, P., unpublished results). 
Our studies of the G2 arrest after DNA damage provide 
clear evidence for the importance of inhibitory phosphory- 
lation at this checkpoint. Expression of CDC2AF, but not 
CDK2AF,  resulted  in  a  considerable  reduction  in  the 
length  of the  G2 arrest induced  by DNA damage. Thus, 
Jin et al. CDC2 Phosphorylation and Radiation Arrest  969 we conclude that inhibitory phosphorylation of CDC2 is at 
least partly responsible for the mitotic delay that occurs af- 
ter DNA damage. 
We have also presented  evidence that mechanisms  not 
involving inhibitory phosphorylation of CDC2 contribute 
to the control of mitosis after DNA damage. First, we ob- 
served that although CDC2AF greatly reduced the G2 ar- 
rest after DNA damage, there was still a significant mitotic 
delay  of  several  hours.  Second,  we  found  that  cells  ar- 
rested in G2 after DNA damage contain high levels of cy- 
clin B1- and CDC2-associated kinase activity. This obser- 
vation is reminiscent of the high Cdc28-associated kinase 
activity in S.  cerevisiae after DNA damage (Amon et al., 
1992; Sorger and Murray, 1992), and raises once again the 
question of why mitosis is not occurring despite the appar- 
ent presence of abundant CDC2 activity. Several possible 
explanations  exist.  For  example,  CDC2  activity  may  be 
suppressed in vivo by an inhibitory protein that binds with 
such low affinity that it is lost during the washing of CDC2 
immunoprecipitates. Alternatively, DNA damage may not 
act through the direct inhibition of CDC2 activity; instead, 
some  function downstream  of CDC2  may be blocked.  It 
also  remains  possible  that other activities  in addition to 
CDC2 are required for the induction of mitosis. 
The cytoplasmic localization of cyclin B  during S phase 
and G2 might also provide an explanation for the inability 
of CDC2AF to completely bypass the DNA damage check- 
point. Immunofluorescence studies have shown that cyclin 
B is primarily cytoplasmic in damage-arrested cells (Smeets 
et al., 1994)(Jin, P., unpublished results). Thus, DNA dam- 
age could act both by stabilizing inhibitory phosphoryla- 
tion of CDC2 and by maintaining the cytoplasmic localiza- 
tion of cyclin B. 
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